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Mortality and detailed characteristics 
of pre-ICU qSOFA-negative patients 
with suspected sepsis: an observational study
Izumi Nakayama1, Junichi Izawa2,3*, Hideyuki Mouri4, Tetsuhisa Kitamura5 and Junji Shiotsuka4
Abstract 
Background: Recent studies have suggested that quick Sequential Organ Failure Assessment (qSOFA) scores have 
limited utility in early prognostication in high-mortality populations. The purpose of this study was to investigate the 
association between pre-ICU qSOFA scores and in-hospital mortality among patients admitted to the ICU with sus-
pected sepsis. This study also aimed to describe detailed clinical characteristics of qSOFA-negative (< 2) patients.
Methods: This single center, observational study, conducted in a Japanese tertiary care teaching hospital between 
May 2012 and June 2016, enrolled all consecutive adult patients admitted to the ICU with suspected sepsis. We 
assessed pre-ICU qSOFA scores with the most abnormal vital signs during the 24-h period before ICU admission. The 
primary outcome was in-hospital mortality censored at 90 days. We analyzed the association between pre-ICU qSOFA 
scores and in-hospital mortality.
Results: Among 185 ICU patients with suspected sepsis, 14.1% (26/185) of patients remained qSOFA-negative at the 
time of ICU admission and 29.2% (54/185) of patients died while in hospital. In-hospital mortality was similar between 
the groups (qSOFA-positive [≥ 2]: 30.2% [48/159] vs qSOFA-negative: 23.1% [6/26], p = 0.642). The Cox proportional 
hazard regression model revealed that being qSOFA-positive was not significantly associated with in-hospital mortal-
ity (adjusted hazard ratio 1.35, 95% confidence interval 0.56–3.22, p = 0.506). Bloodstream infection, immunosuppres-
sion, and hematologic malignancy were observed more frequently in qSOFA-negative patients.
Conclusions: Among ICU patients with suspected sepsis, we could not find a strong association between pre-ICU 
qSOFA scores and in-hospital mortality. Our study suggested high mortality and bacterial diversity in pre-ICU qSOFA-
negative patients.
Keywords: Intensive care unit, Critical care, Bacteremia, Sepsis, quick Sequential Organ Failure Assessment (qSOFA) 
score, Infection, Mortality
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Background
Early identification and interventions have been shown 
to improve sepsis outcomes [1, 2]. Recently, the quick 
Sequential Organ Failure Assessment (qSOFA) score 
was developed to promptly identify infected patients at 
risk of mortality. The original study showed that qSOFA-
positive (≥ 2) patients had a 3- to 14-fold increase in 
in-hospital mortality compared to qSOFA-negative (< 2) 
patients [3]. With its simple and repeatedly measurable 
property, qSOFA has had a promising role in providing a 
more effective triage for infected patients [4].
However, recent studies have suggested that qSOFA has 
limited utility in early prognostication in high-mortality 
populations. One study showed that almost one-half of 
patients with infection remained qSOFA-negative even 
at the time of ICU admission [5]. In studies enrolling 
patients admitted to the ICU, the mortality of qSOFA-
negative patients was greater than 10% [5–9]. Thus, the 
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usefulness of qSOFA scores in high-risk populations has 
remained controversial.
We hypothesized that, for patients with suspected 
sepsis requiring ICU admission, the prognostic impact 
of qSOFA-positive was small. The purpose of this study 
was to investigate the association between pre-ICU 
qSOFA scores, assessed during the 24-h period before 
ICU admission, and in-hospital mortality among patients 
admitted to the ICU with suspected sepsis. Furthermore, 
we described detailed clinical characteristics of qSOFA-
negative patients including clinical diagnosis, primary 
sites of infection, causative organisms, and comorbidi-
ties. Given this description, we aimed to disclose features 
of patients whose risk of mortality was difficult to esti-
mate using qSOFA.
Methods
Study design, setting, and patients
This was an observational study conducted at the 
Okinawa Chubu Hospital, a tertiary care teaching hos-
pital with 550 hospital beds and 14 ICU beds in Japan, 
between May 2012 and June 2016. The hospital institu-
tional review board approved the study protocol (H28-
14). Because of the retrospective approach of this study 
and de-identification of personal data, the board waived 
the need for informed consent.
We examined data of all adult (≥ 18  years) patients 
who were admitted to the ICU between May 2012 and 
June 2016. We identified consecutive patients with sus-
pected sepsis through the following inclusion criteria: 
the documentation of the reason for ICU admission as 
‘bacteremia,’ ‘sepsis,’ ‘severe sepsis,’ or ‘septic shock’ in 
the ICU register. Each documentation was based on the 
clinical judgment as having a severe infection requiring 
ICU admission. Two attending physicians reviewed the 
patient data and agreed on the clinical suspicion of infec-
tion. We excluded patients with cardiac arrest prior to 
ICU admission because we did not expect an additional 
predictive value of qSOFA in these patients.
Data collection
Data for analyses including age, sex, chronic health con-
ditions, location prior to ICU admission, vital signs and 
qSOFA scores before ICU admission, the presence of 
rigor (‘shaking chills’), primary site of infection, type of 
organisms, length of ICU stay, the prevalence of bactere-
mia and in-hospital mortality were collected from patient 
records. According to a previous report from our insti-
tution [10], we routinely classified the qualitative degree 
of rigor (‘chills’) as follows: ‘mild chills,’ feeling cold with 
the need for an outer jacket; ‘moderate chills,’ feeling 
very cold with the need for a thick blanket; and ‘shak-
ing chills,’ a profound chill with generalized involuntary 
bodily shaking, even under a thick blanket. Physicians 
were instructed to record the degree of chills when they 
suspected bacteremia in daily practice. We described 
the primary site of infection as bloodstream, respiratory, 
gastrointestinal, neurological, genitourinary, or muscu-
loskeletal infection based on the clinical context. Blood-
stream infection was defined as blood culture-positive 
infection including infective endocarditis, bacteremia 
from an unknown origin and catheter-related bactere-
mia. The primary infection site showed the following 
organism types, namely gram-negative bacterial infec-
tion, gram-positive bacterial infection, polymicrobial 
infection or fungal infection. Illness severity was assessed 
using the Acute Physiology and Chronic Health Evalua-
tion (APACHE) II [11] and the Sequential Organ Failure 
Assessment (SOFA) scores [12] with the most abnormal 
measurements recorded during the first 24-h period after 
ICU admission (Additional file  1: Fig. S1). We used the 
worst SOFA scores and defined sepsis as a SOFA score of 
≥ 2 according to the Sepsis-3 definition [4].
Measurement of the main exposure factors (Additional 
file 1: Fig. S1)
The qSOFA score had three criteria, assigning one point 
for alteration in mental status (Glasgow Coma Scale 
< 15), systolic blood pressure ≤ 100  mm, Hg or respira-
tory rate ≥ 22/min [4]. We evaluated pre-ICU qSOFA 
scores with the most abnormal vital signs at the time of 
clinical deterioration during the 24-h period before ICU 
admission. We set this time window to evaluate the per-
formance value of pre-ICU admission qSOFA scores in 
prognosticating high-risk patients before ICU transfer. 
We also aimed to avoid the effect of therapeutic inter-
ventions during the ICU stay on qSOFA scores. Accord-
ing to a previous study, we defined qSOFA-positive or 
qSOFA-negative as a qSOFA score of ≥ 2 or < 2, respec-
tively [3]. We also evaluated pre-ICU systemic inflamma-
tory response syndrome (SIRS) with the most abnormal 
measurements during the 24-h period before ICU admis-
sion. SIRS-positive was defined as two or more of the fol-
lowing: temperature > 38 or < 36 °C, heart rate > 90 beats/
min, respiratory rate > 20 breaths/min, or arterial carbon 
dioxide pressure < 32  mm Hg, white blood cell count 
> 12,000/μL or < 4000/μL [13]. In addition, we evaluated 
qSOFA scores and SIRS at the exact moment of ICU 
arrival using the first measurements of vital signs just 
after ICU admission.
Outcome measures
The primary outcome measure was in-hospital mortal-
ity, which was defined as any cause of death censored at 
90  days after ICU admission. Other outcomes included 
the length of ICU stay, ICU stay ≥ 3  days, bacteremia 
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and in-hospital mortality censored at 28 days after ICU 
admission. We defined bacteremia as 2 sets of blood 
culture with the same microorganism or 1 set of blood 
culture with bacteria, except for possible contaminated 
resources involving Coagulase-negative Staphylococci, 
Corynebacterium species, Propionibacterium species, 
Bacillus species, Aerococcus species, and Micrococcus 
species [14, 15].
Statistical analysis
Continuous data are presented as medians with inter-
quartile range (IQR) and compared using the Mann–
Whitney U test. Categorical data are presented as 
proportions and compared using a Chi-squared test or 
Fisher’s exact test when appropriate. We used Kaplan–
Meier plots to describe the survival between qSOFA-
positive and qSOFA-negative patients and compared the 
survival curves with the log-rank test. As the primary 
analysis, the Cox proportional hazard regression model 
was used to assess the association between being qSOFA-
positive before ICU admission and in-hospital mortal-
ity censored at 90 days after ICU admission. The hazard 
ratio (HR) and 95% confidence interval (CI) were calcu-
lated. The following variables were incorporated into the 
primary multivariable models: age, the presence of rigor 
(‘shaking chills’), prior location to the ICU, and chronic 
health condition with immunosuppression. In the 
Kaplan–Meier description and the Cox regression anal-
ysis, if survival hospital discharge occurs within 90 days 
after ICU admission, we dealt with it as censoring. We 
also estimated the performance of pre-ICU qSOFA, pre-
ICU SIRS, qSOFA at ICU arrival, and SIRS at ICU arrival 
in predicting sepsis by the Sepsis-3 and in-hospital mor-
tality censored at 90  days. The crude risk ratios (RRs) 
with 95% CI and area under receiver operating character-
istics (AUROC) were calculated. We used qSOFA scores 
and SIRS scores as continuous variables for the calcula-
tion of AUROCs. All statistical analyses were performed 
using R (The R Foundation for Statistical Computing, 
ver.3.2.4) and EZR (Saitama Medical Center, Jichi Medi-
cal University, ver.1.32), which is a graphical user inter-
face for R [16]. All tests were two-tailed; p values of less 
than 0.05 were regarded as statistically significant.
Results
The patient flow diagram is presented in Fig.  1. We 
extracted 188 patients who were admitted to the ICU 
with suspected sepsis. After excluding 3 patients with 
prior cardiac arrest, we enrolled 185 patients for our anal-
yses. At least 2 sets of blood cultures were obtained from 
all participants. The median age was 67 (IQR 57–79), and 
61.1% (113/185) of patients were from the emergency 
room (ER) and 33.5% (62/185) of patients had at least 
one chronic health condition. Among 185 patients, 85.9% 
(159/185) were qSOFA-positive and 89.7% (166/185) 
were SIRS-positive before ICU admission. The median 
APACHE II and SOFA scores were 21 (IQR 17–28) and 
9 (IQR 5–11), respectively. In total, 91.9% (170/185) of 
patients fulfilled the Sepsis-3 definition, 53.0% (98/185) 
had positive blood culture, and 29.2% (54/185) died in 
hospital within 90 days after ICU admission.
Patient demographics, characteristics at the presenta-
tion of infection, and characteristics after ICU admis-
sion are presented in Table  1. While qSOFA-positive 
patients were presented with more deranged vital signs, 
qSOFA-negative patients were more frequently from 
the ward (qSOFA-positive: 35.8% [57/159] vs qSOFA-
negative: 57.7% [15/26], p = 0.050) and more frequently 
had shaking chills (qSOFA-positive: 27.7% [44/159] vs 
qSOFA-negative: 53.8% [14/26], p = 0.011). Hematologic 
malignancy (qSOFA-positive: 5.7% [9/159] vs qSOFA-
negative: 15.4% [4/26], p = 0.090) and immunosuppres-
sion (qSOFA-positive: 5.7% [9/159] vs qSOFA-negative: 
15.4% [4/26], p = 0.090) were also observed more fre-
quently in qSOFA-negative patients. The degree of organ 
dysfunction was similar between the groups in relation to 
respiration, coagulation, and liver and renal components 
of the SOFA scores.
The outcomes of qSOFA-negative patients were similar 
to those of qSOFA-positive patients (Fig. 2 and Table 2). 
The primary outcome, in-hospital mortality censored 
at 90  days after ICU admission, was not significantly 
different between the groups (qSOFA-positive: 30.2% 
[48/159] vs qSOFA-negative: 23.1% [6/26], p = 0.642). 
The other outcomes, ICU length of stay (qSOFA-pos-
itive: 3 [2–6] vs qSOFA-negative: 3 [2–5], p = 0.787), 
Patients admitted to ICU with 
suspected sepsis
and aged ≥18 
N = 188
Cardiac arrest 










Fig. 1 Flow of patients admitted to the ICU with suspected sepsis 
from 2012 to 2016. ICU denotes intensive care unit, qSOFA quick 
Sequential Organ Failure Assessment
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bacteremia (qSOFA-positive: 53.5% [85/159] vs qSOFA-
negative: 50.0% [13/26], p = 0.833), and 28-day mortal-
ity (qSOFA-positive: 25.2% [40/159] vs qSOFA-negative: 
19.2% [5/26], p = 0.627) were also similar between the 
groups. The Kaplan–Meier plots of survival showed no 
significant difference between the groups (p = 0.514). The 
Cox proportional hazard regression model revealed that 
pre-ICU qSOFA-positive was not significantly associ-
ated with in-hospital mortality (adjusted HR 1.35, 95% CI 
0.56–3.22, p = 0.506).
Detailed microbiological results are presented in 
Table  3. Among primary sites of infection, bloodstream 
infection was more frequent in qSOFA-negative patients 
(qSOFA-positive: 18.2% [29/159] vs qSOFA-negative: 
30.8% [8/26], p = 0.094). Among identified organisms, 
Staphylococcus aureus infection was more frequent 
in qSOFA-negative patients (qSOFA-positive: 8.8% 
[14/159] vs qSOFA-negative: 15.4% [4/26], p = 0.290). Of 
26 qSOFA-negative patients, the most common site of 
infection was bloodstream infection (30.8% [8/26]), fol-
lowed by genitourinary infection (23.1% [6/26]). Among 
qSOFA-negative patients who died in the hospital, all the 
patients had at least one chronic health condition.
Table 1 Characteristics before and after ICU admission in patients with suspected sepsis
qSOFA scores were assessed with the most abnormal vital signs during the 24-h period before the ICU admission. SOFA and APACHE II scores were calculated with the 
most abnormal measurements taken during the first 24-h period after the ICU admission
APACHE II Acute Physiology and Chronic Health Evaluation II, ICU intensive care unit, IQR interquartile range, qSOFA quick Sequential Organ Failure Assessment, SOFA 
Sequential Organ Failure Assessment
qSOFA-positive (≥ 2) qSOFA-negative (< 2) p value
(N = 159) (N = 26)
Demographics
Age (median [IQR]) 67 [57–79] 68 [63–75] 0.791
Male (%) 95 (59.7%) 16 (61.5%) 1.000
Chronic health condition (%)
 Metastatic cancer 7 (4.4%) 1 (3.8%) 1.000
 Chronic dialysis 22 (13.8%) 4 (15.4%) 0.767
 Hepatic failure 15 (9.4%) 2 (7.7%) 1.000
 Chronic respiratory failure 4 (2.5%) 1 (3.8%) 0.535
 Hematologic malignancy 9 (5.7%) 4 (15.4%) 0.090
 Immunosuppression 9 (5.7%) 4 (15.4%) 0.090
Characteristics at the presentation of infection
Location prior to ICU admission (%) 0.050
 Emergency room 102 (64.2%) 11 (42.3%)
 General ward 57 (35.8%) 15 (57.7%)
Vital signs before ICU admission (median [IQR])
 Systolic blood pressure, mm Hg 82 [70–96] 105 [79–120] 0.004
 Respiratory rate,/min 28 [24–30] 20 [20–24] < 0.001
 Glasgow coma scale 13 [9–15] 15 [15–15] < 0.001
 Heart rate,/min 116 [101–132] 110 [88–119] 0.047
 Body temperature, Celsius 38.2 [37.2–39.1] 38.2 [37.1–39.2] 0.997
Shaking chills (%) 44 (27.7%) 14 (53.8%) 0.011
Characteristics after ICU admission
APACHE II (median [IQR]) 22 [17–29] 20 [15–24] 0.092
SOFA score (median [IQR]) 9 [6–12] 6 [3–8] 0.001
 SOFA respiration 2 [1–3] 1 [0–3] 0.112
 SOFA coagulation 1 [0–2] 1 [0–2] 0.256
 SOFA liver 0 [0–1] 0 [0–0] 0.296
 SOFA central nervous system 1 [0–3] 0 [0–0] < 0.001
 SOFA renal 1 [0–3] 1 [0–2] 0.887
 SOFA cardiovascular 3 [1–4] 1 [0–3] < 0.001
Lactate, mmol/L (median [IQR]) 2.5 [1.5–5.3] 1.5 [0.9–3.5] 0.075
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The performance of qSOFA and SIRS in predicting 
sepsis and mortality is shown in Table  4. The associa-
tion between pre-ICU qSOFA or pre-ICU SIRS and in-
hospital mortality censored at 90 days was not significant 
(qSOFA crude RR 1.38, 95% CI 0.62–2.74, AUROC 0.511; 
SIRS crude RR 0.92, 95% CI 0.45–1.85, AUROC 0.521). 
On the other hand, qSOFA at ICU arrival was signifi-
cantly associated with in-hospital mortality censored 
at 90  days (crude RR 1.78, 95% CI 1.09–2.89, AUROC 
0.586).
Discussion
Our study suggested that the prognostic impact of pre-
ICU qSOFA, assessed during the 24-h period before ICU 
admission, was small among patients with suspected 
sepsis (HR 1.35, 95% CI 0.56–3.22). In this study, com-
prised of high-mortality (29.2%) patients, 14% (26/185) 
of patients remained qSOFA-negative even at the time 
of ICU admission. Moreover, the difference in in-hos-
pital mortality was small (qSOFA-positive: 30.2% vs 
qSOFA-negative: 23.1%, p = 0.642). Importantly, our 
study suggested that the risk of mortality in patients with 
bloodstream infection, immunosuppression or hema-
tologic malignancy would be difficult to estimate using 
qSOFA scores. The results of our study may provide 
important implications for clinicians in early prognosti-
cation of patients with suspected sepsis and for develop-
ers of sepsis screening systems.
Among patients with suspected infection outside the 
ICU, qSOFA scores had greater prognostic accuracy than 
SIRS [3]. Since 1992, SIRS has gained widespread accept-
ance as the clinical definition of sepsis [13]. However, the 
specificity of SIRS ≥ 2 was too low and 70–90% of ICU 
patients, including non-infected patients, attained SIRS 
≥ 2 during their ICU stay [17]. Along with the develop-
ment of a new definition for sepsis, the qSOFA score has 
been generated to guide bedside clinicians in identifying 
infected patients at risk of in-hospital mortality or longer 
ICU stay [3]. The original study showed that qSOFA-pos-
itive patients had a 3- to 14-fold increase in in-hospital 
mortality compared to qSOFA-negative patients when 
qSOFA scores were assessed during the 72-h period 
around the onset of infection. Further external validation 
studies have shown that qSOFA scores had greater prog-
nostic accuracy than SIRS among patients presenting to 
the ER [18–20].
However, recent studies have suggested that qSOFA has 
limited utility in early prognostication in high-mortality 
populations. In a retrospective analysis of a large adult 
ICU patient database, qSOFA assessed during the first 
24-h following ICU admission had little additional pre-
dictive value for mortality over SIRS [6]. In recent stud-
ies consisting of patients admitted to the ICU or patients 
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Fig. 2 Kaplan–Meier curves of in-hospital mortality censored at 
90 days stratified as pre-ICU qSOFA-positive or qSOFA-negative. 
aAdjusted for age, the presence of rigor (‘shaking chills’), prior location 
to the ICU and chronic health condition with immunosuppression. 
CI confidence interval, HR hazard ratio, ICU intensive care unit, qSOFA 
quick Sequential Organ Failure Assessment. The vertical tick marks on 
the curves denote censoring due to survival discharge
Table 2 ICU stay and in-hospital mortality in ICU patients with suspected sepsis
qSOFA scores were assessed with the most abnormal vital signs taken during the 24-h period before the ICU admission
In-hospital mortality was defined as any cause of death censored at 28 days or at 90 days after the ICU admission
ICU intensive care unit, IQR interquartile range, qSOFA quick Sequential Organ Failure Assessment
qSOFA-positive (≥ 2) qSOFA-negative (< 2) p value
(N = 159) (N = 26)
ICU length of stay (median [IQR]) 3 [2–6] 3 [2–5] 0.787
ICU stay ≥ 3 days (%) 94 (59.1%) 15 (57.7%) 1.000
Bacteremia (%) 85 (53.5%) 13 (50.0%) 0.833
In-hospital mortality (%)
 28-day mortality 40 (25.2%) 5 (19.2%) 0.627
 90-day mortality 48 (30.2%) 6 (23.1%) 0.642
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in the ward, in-hospital mortality of qSOFA-negative 
patients was higher (13.6–17.4%) compared to mortal-
ity in studies consisting of ER patients [5–9]. Therefore, 
qSOFA was assumed to have limited performance value 
in prognosticating high-risk patients. Importantly, 
qSOFA scores assessed after ICU admission were likely 
to have been affected with therapeutic interventions such 
as vasopressors and sedative agents [3, 6]. Therefore, pre-
ICU qSOFA scores assessed before ICU admission have 
been evaluated [21].
We focused on patients with suspected sepsis requir-
ing ICU admission and evaluated pre-ICU qSOFA scores 
assessed during the 24-h period before ICU admission. 
Our results raise a question as to why the association 
between pre-ICU qSOFA-positive and mortality was 
weaker (HR 1.35, 95% CI 0.56–3.22) than that observed 
in previous studies [3, 18]. To address this question, 
it is to be noted, first, that our patients were judged as 
having a severe infection by treating physicians before 
enrollment. Physicians detected signs of severe infec-
tion based not only on vital sign abnormalities such as 
qSOFA components but also on clinical diagnosis, pri-
mary sites of infection, presumed causative organisms 
and patient comorbidities [22, 23]. Also, some experts 
have questioned the sensitivity of qSOFA because qSOFA 
would remain negative until life-threatening organ dys-
function has developed [24]. A previous study showed 
that qSOFA remained negative even at the time of ICU 
transfer in one-half of infected patients [5]. In our study, 
the association between qSOFA and mortality became 
significant only after ICU admission (Pre-ICU qSOFA: 
crude RR 1.38, 95% CI 0.62–2.74; qSOFA at ICU arrival: 
crude RR 1.78, 95% CI 1.09–2.89). Physicians might have 
detected the risk of further clinical deterioration before 
qSOFA was determined as positive. As a result, the asso-
ciation between pre-ICU qSOFA and mortality would 
have attenuated. Our results suggested that qSOFA had 
little additional predictive value for mortality over clinical 
judgment (Fig. 2, Table 4). Second, we presented 90-day 
mortality instead of 28-day mortality. Recent studies have 
shown that patients with sepsis had increasing mortality 
beyond the standard 28-day mortality and that the use of 
long-term outcomes had been postulated to infer the full 
impact of sepsis [25]. Our study represented long-term 
outcomes of infected patients requiring ICU admission.
In addition to investigating the association between 
qSOFA-positive and mortality, we described detailed 
characteristics in qSOFA-negative patients to disclose 
Table 3 Microbiological results in ICU patients with suspected sepsis
qSOFA scores were assessed with the most abnormal vital signs taken during the 24-h period before the ICU admission
Bloodstream infection was defined as blood culture-positive infection including infective endocarditis, bacteremia from an unknown origin and catheter-related 
bacteremia
ICU intensive care unit, NA not applicable, qSOFA quick Sequential Organ Failure Assessment
qSOFA-positive (≥ 2) qSOFA-negative (< 2) p value
(N = 159) (N = 26)
Primary site of infection (%)
 Bloodstream 29 (18.2%) 8 (30.8%) 0.094
 Respiratory 31 (19.5%) 3 (11.5%) 0.573
 Gastrointestinal 25 (15.7%) 4 (15.4%) 0.770
 Neurological 2 (1.3%) 0 (0.0%) NA
 Genitourinary 39 (24.5%) 6 (23.1%) 1.000
 Musculoskeletal 19 (11.9%) 1 (3.8%) 0.476
 Other 14 (8.8%) 4 (15.4%) 0.290
Type of organisms (%)
 Gram-negative bacterial infection 66 (41.5%) 11 (42.3%)
  Escherichia coli 30 (18.9%) 5 (19.2%) 1.000
  Klebsiella pneumoniae 12 (7.5%) 1 (3.8%) 0.697
  Pseudomonas aeruginosa 7 (4.4%) 0 (0.0%) NA
 Gram-positive bacterial infection 32 (20.1%) 6 (23.1%)
  Staphylococcus aureus 14 (8.8%) 4 (15.4%) 0.290
  Streptococcus pneumoniae 9 (5.7%) 0 (0.0%) NA
  Streptococcus species 4 (2.5%) 1 (3.8%) 0.535
 Polymicrobial infection 20 (12.6%) 4 (15.4%) 0.752
 Fungal infection 4 (2.5%) 0 (0.0%) NA
 Not specified 37 (23.3%) 5 (19.2%) 0.803
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features of patients whose risk of mortality was diffi-
cult to estimate using qSOFA scores (Table  1, 3). The 
characteristics, which were more frequently found in 
qSOFA-negative patients, were hematologic malig-
nancy, immunosuppression, bloodstream infection, and 
Staphylococcus aureus infection. Among 8 bloodstream 
infections in qSOFA-negative patients, 37.5% (3/8) had 
chronic dialysis, and 25% (2/8) had hematologic malig-
nancy. We think that the history of comorbidities alerted 
physicians of further deterioration and prompted phy-
sicians to consider ICU transfer before qSOFA scores 
turned positive. A variety of infections were presented 
with qSOFA-negative patients in our study. Indeed, we 
often experienced infective endocarditis, catheter-related 
bacteremia, pyelonephritis, and bacterial pneumonia 
in qSOFA-negative patients. Of note, all the patients 
who died in the qSOFA-negative group had at least one 
chronic health condition. In these patients, primary sites 
of infection and comorbidities would be additional useful 
information for early prognostication.
Our study had several limitations. First, our study 
was conducted in a single center with a small number 
of patients. As a result, only 54 in-hospital deaths were 
observed and the CI for our primary analyses was wide 
(HR 1.35, 95% CI 0.56–3.22). It is possible that we failed 
to find an association between pre-ICU qSOFA and in-
hospital mortality due to the small sample size. Because 
no study focused on pre-ICU qSOFA at the time we 
planned the study, it was difficult to estimate a priori 
sample size. Second, because we did not observe all the 
infected patients presented to the ER or the ward, it is 
possible that we did not accurately estimate the asso-
ciation between qSOFA and mortality in patients not 
requiring ICU admission. The generalizability of the 
result of this study might have been attenuated. Cur-
rently, however, only a few studies have focused on pre-
ICU qSOFA scores and on qSOFA-negative, infected 
ICU patients [21]. The results of our study provide an 
important basis for further prospective studies inves-
tigating the role of qSOFA in triage decisions for ICU 
admission. Third, we did not use uniform criteria for ICU 
admission. The threshold of ICU transfer in each patient 
largely depends on physicians and hospital-beds avail-
ability. Nevertheless, the median APACHE II scores (21, 
IQR 17–28), SOFA scores (9, IQR 5–11), and mortality 
(29.2%) of our patients were higher than those of related 
studies [3, 6, 18] or than in recent multicenter studies 
enrolling patients with early septic shock (mortality 18%) 
[26]. Thus, our results reflected the performance value of 
qSOFA in high-risk populations. Last, due to the retro-
spective nature of our study, the frequency of qSOFA var-
iable measurements was not standardized. The pre-ICU 
qSOFA scores in our study were based on the worst vital 
signs that were obtainable during the 24-h period before 
ICU admission. There were no missing data regarding 
qSOFA scores.
Table 4 Performance of qSOFA and SIRS in predicting sepsis and mortality
Pre-ICU qSOFA and SIRS scores were assessed with the most abnormal vital signs taken during the 24-h period before the ICU admission. qSOFA and SIRS scores at ICU 
arrival were assessed with the first measurements just after ICU admission
Sepsis was defined according to the Sepsis-3 definition. In-hospital mortality was defined as any cause of death censored at 90 days after the ICU admission
AUROC area under receiver operating characteristics, CI confidence interval, ICU intensive care unit, qSOFA quick Sequential Organ Failure Assessment, SIRS systemic 
inflammatory response syndrome
Sepsis by Sepsis-3 definition In-hospital mortality
n/N (%) Crude risk ratio (95% CI) AUROC n/N (%) Crude risk ratio (95% CI) AUROC
Pre-ICU qSOFA 0.711 0.511
 qSOFA-positive (≥ 2) 149/159 (93.7%) 1.16 (0.96–1.41) 48/159 (30.2%) 1.38 (0.62–2.74)
 qSOFA-negative (< 2) 21/26 (80.8%) 1.00 (ref ) 6/26 (23.1%) 1.00 (ref )
Pre-ICU SIRS 0.710 0.521
 SIRS-positive (≥ 2) 155/166 (93.4%) 1.18 (0.93–1.50) 48/166 (28.9%) 0.92 (0.45–1.85)
 SIRS-negative (< 2) 15/19 (78.9%) 1.00 (ref ) 6/19 (31.6%) 1.00 (ref )
qSOFA at ICU arrival 0.624 0.586
 qSOFA-positive (≥ 2) 92/98 (93.9%) 1.05 (0.96–1.14) 36/98 (36.7%) 1.78 (1.09–2.89)
 qSOFA-negative (< 2) 78/87 (89.7%) 1.00 (ref ) 18/87 (20.7%) 1.00 (ref )
SIRS at ICU arrival 0.709 0.541
 SIRS-positive (≥ 2) 133/139 (95.7%) 1.19 (1.03–1.38) 41/139 (29.5%) 1.04 (0.62–1.77)
 SIRS-negative (< 2) 37/46 (80.4%) 1.00 (ref ) 13/46 (28.3%) 1.00 (ref )
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Conclusion
In this observational study, among patients admitted to 
the ICU with suspected sepsis, we could not find a strong 
association between pre-ICU qSOFA scores and in-hos-
pital mortality. We described high mortality and bacterial 
diversity in pre-ICU qSOFA-negative patients. Besides 
qSOFA scores, primary sites of infection and comorbidi-
ties may provide additional useful information for early 
prognostication in high-risk populations.
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